These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31785550)

  • 1. Videos to reduce racial disparities in ICD therapy Via Innovative Designs (VIVID) trial: Rational, design and methodology.
    Thomas KL; Sullivan LT; Al-Khatib SM; LaPointe NA; Sears S; Kosinski AS; Jackson LR; Kutyifa V; Peterson ED
    Am Heart J; 2020 Feb; 220():59-67. PubMed ID: 31785550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assisting Black Patients With Decision-Making for Implantable Cardioverter Defibrillator Therapy: Qualitative Findings From the Videos to Reduce Racial Disparities in ICD Therapy via Innovative Designs (VIVID) Trial.
    Jackson LR; McKenna K; Corneli A; Dombeck C; Brelsford K; Thomas KL
    Circ Cardiovasc Qual Outcomes; 2024 Jul; 17(7):e010550. PubMed ID: 38864226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Educational videos to reduce racial disparities in ICD therapy via innovative designs (VIVID): a randomized clinical trial.
    Thomas KL; Zimmer LO; Dai D; Al-Khatib SM; Allen LaPointe NM; Peterson ED
    Am Heart J; 2013 Jul; 166(1):157-63. PubMed ID: 23816035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitating Shared Decision Making Among Black Patients at Risk for Sudden Cardiac Arrest : A Randomized Clinical Trial.
    Thomas KL; Al-Khatib SM; Kosinski AS; Sears SF; Allen LaPointe NM; Jackson LR; Matlock DD; Haithcock D; Colley BJ; Hirsh DS; Peterson ED
    Ann Intern Med; 2023 May; 176(5):615-623. PubMed ID: 37011387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression and Implantable Cardioverter-Defibrillator Implantation in Black Patients at Risk for Sudden Cardiac Death.
    Boursiquot BC; Young R; Alhanti B; Sullivan LT; Maul AJ; Khedagi A; Sears SF; Jackson LR; Thomas KL
    J Am Heart Assoc; 2024 Jul; 13(14):e033291. PubMed ID: 38979811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and gender disparities in implantable cardioverter-defibrillator placement: are they due to overuse or underuse?
    Cook NL; Orav EJ; Liang CL; Guadagnoli E; Hicks LS
    Med Care Res Rev; 2011 Apr; 68(2):226-46. PubMed ID: 20829236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial disparity and technology diffusion: the case of cardioverter defibrillator implants, 1996-2001.
    Stanley A; DeLia D; Cantor JC
    J Natl Med Assoc; 2007 Mar; 99(3):201-7. PubMed ID: 17393943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients.
    Pokorney SD; Hellkamp AS; Yancy CW; Curtis LH; Hammill SC; Peterson ED; Masoudi FA; Bhatt DL; Al-Khalidi HR; Heidenreich PA; Anstrom KJ; Fonarow GC; Al-Khatib SM
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):145-51. PubMed ID: 25504649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the utilization of implantable cardioverter defibrillators for sudden cardiac arrest prevention (Improve SCA) in developing countries: Clinical characteristics and reasons for implantation refusal.
    Singh B; Zhang S; Ching CK; Huang D; Liu YB; Rodriguez DA; Hussin A; Kim YH; Chasnoits AR; Cerkvenik J; Muckala KA; Cheng A
    Pacing Clin Electrophysiol; 2018 Dec; 41(12):1619-1626. PubMed ID: 30320410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' decision making to accept or decline an implantable cardioverter defibrillator for primary prevention of sudden cardiac death.
    Carroll SL; Strachan PH; de Laat S; Schwartz L; Arthur HM
    Health Expect; 2013 Mar; 16(1):69-79. PubMed ID: 21645190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in the use of primary prevention and defibrillator therapy among blacks and women.
    Gauri AJ; Davis A; Hong T; Burke MC; Knight BP
    Am J Med; 2006 Feb; 119(2):167.e17-21. PubMed ID: 16443424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of Thomas KL; Al-Khatib SM; Kelsey RC; Bush H; Brosius L; Velazquez EJ; Peterson ED; Gilliam FR
    Am J Cardiol; 2007 Sep; 100(6):924-9. PubMed ID: 17826371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Referral Patterns for Primary Prophylaxis Implantable Cardioverter Defibrillator Therapy for an Urban US Population.
    Manheimer ED; Gonzalez C; Turk J; Krumerman AK; Kim SG; Gross JN; Palma EC; Grushko MJ; Fisher JD; Ferrick KJ
    Am J Cardiol; 2015 Oct; 116(8):1210-2. PubMed ID: 26320756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of government-mandated shared decision-making for implantable defibrillators: A natural experiment.
    Rao BR; Merchant FM; Abernethy ER; Howard DH; Matlock DD; Dickert NW
    Pacing Clin Electrophysiol; 2022 Feb; 45(2):274-280. PubMed ID: 34843128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and Ethnic Disparities in Implantable Cardioverter-Defibrillator Utilization: A Contemporary Review.
    Tertulien T; Bush K; Jackson LR; Essien UR; Eberly L
    Curr Treat Options Cardiovasc Med; 2023 Dec; 25(12):771-791. PubMed ID: 38873495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD).
    Zhang Y; Kennedy R; Blasco-Colmenares E; Butcher B; Norgard S; Eldadah Z; Dickfeld T; Ellenbogen KA; Marine JE; Guallar E; Tomaselli GF; Cheng A
    Heart Rhythm; 2014 Aug; 11(8):1377-83. PubMed ID: 24793459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decisional balance among potential implantable cardioverter defibrillator recipients: development of the ICD-decision analysis scale (ICD-DAS).
    Hazelton AG; Sears SF; Ford J; Cahill J; Nekkanti R; Deantonio H; Ottoboni L; Norton L; Wang P
    Pacing Clin Electrophysiol; 2014 Jan; 37(1):63-72. PubMed ID: 24219117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.
    Eberly LA; Day SM; Ashley EA; Jacoby DL; Jefferies JL; Colan SD; Rossano JW; Semsarian C; Pereira AC; Olivotto I; Ingles J; Seidman CE; Channaoui N; Cirino AL; Han L; Ho CY; Lakdawala NK
    JAMA Cardiol; 2020 Jan; 5(1):83-91. PubMed ID: 31799990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and piloting of four decision aids for implantable cardioverter-defibrillators in different media formats.
    Wallace BC; Jones J; Masoudi FA; Nowels CT; Varosy P; Thomson R; Elwyn G; Brega AG; Vermilye T; Knoepke CE; Sandhu A; Allen LA; Matlock DD
    Pacing Clin Electrophysiol; 2021 Nov; 44(11):1842-1852. PubMed ID: 34528271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' attitudes and perceptions of implantable cardioverter-defibrillators: potential barriers to appropriate primary prophylaxis.
    Yuhas J; Mattocks K; Gravelin L; Remetz M; Foley J; Fazio R; Lampert R
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1179-87. PubMed ID: 22897624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.